| Product NDC: | 0259-0501 |
| Proprietary Name: | Cuvposa |
| Non Proprietary Name: | glycopyrrolate |
| Active Ingredient(s): | 1 mg/5mL & nbsp; glycopyrrolate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | LIQUID |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0259-0501 |
| Labeler Name: | Merz Pharmaceuticals, LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA022571 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20130101 |
| Package NDC: | 0259-0501-16 |
| Package Description: | 1 BOTTLE in 1 CARTON (0259-0501-16) > 473 mL in 1 BOTTLE |
| NDC Code | 0259-0501-16 |
| Proprietary Name | Cuvposa |
| Package Description | 1 BOTTLE in 1 CARTON (0259-0501-16) > 473 mL in 1 BOTTLE |
| Product NDC | 0259-0501 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | glycopyrrolate |
| Dosage Form Name | LIQUID |
| Route Name | ORAL |
| Start Marketing Date | 20130101 |
| Marketing Category Name | NDA |
| Labeler Name | Merz Pharmaceuticals, LLC |
| Substance Name | GLYCOPYRROLATE |
| Strength Number | 1 |
| Strength Unit | mg/5mL |
| Pharmaceutical Classes | Anticholinergic [EPC],Cholinergic Antagonists [MoA] |